Open AccessAcquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
Author(s) -
Guido V. Bloemberg,
Peter M. Keller,
David Stucki,
Andrej Trauner,
Sònia Borrell,
Tsogyal D. Latshang,
Mireia Coscollá,
Thomas Rothe,
Rico Hömke,
Claudia Ritter,
Julia Feldmann,
Bettina Schulthess,
Sébastien Gagneux,
Erik C. Böttger
Publication year - 2015
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmc1505196
Subject(s) - bedaquiline , medicine , tuberculosis , intensive care medicine , medline , mycobacterium tuberculosis , pathology , political science , law
Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom